DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 197 filers reported holding DENALI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $34,637 | -40.4% | 1,679 | -14.8% | 0.00% | – |
Q2 2023 | $58,164 | +73.4% | 1,971 | +35.4% | 0.00% | – |
Q1 2023 | $33,546 | -27.7% | 1,456 | -12.8% | 0.00% | – |
Q4 2022 | $46,415 | +71.9% | 1,669 | +85.2% | 0.00% | – |
Q3 2022 | $27,000 | +12.5% | 901 | +10.1% | 0.00% | – |
Q2 2022 | $24,000 | -11.1% | 818 | -2.4% | 0.00% | – |
Q1 2022 | $27,000 | -58.5% | 838 | -42.3% | 0.00% | – |
Q4 2021 | $65,000 | +6.6% | 1,452 | +19.9% | 0.00% | – |
Q3 2021 | $61,000 | -16.4% | 1,211 | +30.4% | 0.00% | – |
Q2 2021 | $73,000 | +40.4% | 929 | +1.3% | 0.00% | – |
Q1 2021 | $52,000 | -33.3% | 917 | -1.1% | 0.00% | – |
Q4 2020 | $78,000 | +136.4% | 927 | +0.3% | 0.00% | – |
Q3 2020 | $33,000 | +50.0% | 924 | 0.0% | 0.00% | – |
Q2 2020 | $22,000 | +37.5% | 924 | +0.8% | 0.00% | – |
Q1 2020 | $16,000 | +77.8% | 917 | +83.4% | 0.00% | – |
Q4 2019 | $9,000 | +12.5% | 500 | 0.0% | 0.00% | – |
Q3 2019 | $8,000 | -20.0% | 500 | 0.0% | 0.00% | – |
Q2 2019 | $10,000 | -16.7% | 500 | 0.0% | 0.00% | – |
Q1 2019 | $12,000 | +20.0% | 500 | 0.0% | 0.00% | – |
Q4 2018 | $10,000 | -16.7% | 500 | -6.7% | 0.00% | – |
Q3 2018 | $12,000 | +50.0% | 536 | +7.2% | 0.00% | – |
Q2 2018 | $8,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |